Consensus Enovis Corporation

Equities

ENOV

US1940145022

Real-time Estimate Cboe BZX Other stock markets 02:22:56 2024-04-26 pm EDT			5-day change	1st Jan Change
55.44 ^USD	+0.61%		-0.72%	-1.05%

Apr. 09	Transcript : Enovis Corporation Presents at 23rd Annual Needham Virtual Healthcare Conference, Apr-09-2024 03:45 PM
Feb. 23	Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	MT

Evolution of the average Target Price on Enovis Corporation

Price target over the last 5 years

History of analyst recommendation changes

98620aa51f683272fded5cff97a5.O5FtkHspOUtiUOGNGoe6INqbWaygXvttGkWPufw5JWc.Qegi5xR7CgY7EdHfceTyWpH5bMjQKbwMchzZ-5ReXxdk5DfjPWh-LQYdoA~d1dc09d9ea27d89be2d4ea489ef3990d

Analyst Recommendations on Enovis Corporation

Canaccord Genuity Ups Price Target on Enovis to $75 From $73, Maintains Buy Rating	Feb. 23	MT
Needham Raises Price Target on Enovis to $82 From $73, Maintains Buy Rating	Feb. 23	MT
Stephens Initiates Enovis With Overweight Rating, $72 Price Target	Feb. 13	MT
UBS Initiates Coverage on Enovis With Buy Rating, $75 Price Target	Jan. 22	MT
William Blair Initiates Enovis at Outperform Rating	Jan. 03	MT
Canaccord Genuity Adjusts Enovis Price Target to $71 From $65, Maintains Buy Rating	Dec. 20	MT
Needham Adjusts Price Target on Enovis to $70 From $62, Keeps Buy Rating	Dec. 15	MT
Baird Adjusts Price Target on Enovis to $70 From $67, Maintains Outperform Rating	23-08-04	MT
Needham Initiates Enovis With Buy Rating, $70 Price Target	23-06-26	MT
Wells Fargo Upgrades Enovis to Overweight Rating From Equal Weight, Adjusts Price Target to $67 From $55	23-05-12	MT
Baird Adjusts Enovis Price Target to $64 From $68, Maintains Outperform Rating	23-02-24	MT
Baird Adjusts Enovis' Price Target to $68 From $73, Keeps Outperform Rating	22-11-03	MT
Wells Fargo Lowers Enovis' Price Target to $53 From $60, Keeps Equalweight Rating	22-10-26	MT
Jefferies Initiates Enovis at Buy with $60 Price Target	22-10-12	MT
Goldman Sachs Initiates Coverage on Enovis With Buy Rating, $57 Price Target	22-10-11	MT
Evercore ISI Starts Enovis at Outperform With $68 Price Target	22-09-12	MT
Canaccord Genuity Starts Enovis at Buy With $67 Price Target	22-09-12	MT
Argus Initiates Enovis at Hold	22-06-28	MT
Loop Capital Assumes Enovis at Buy with $68 Price Target	22-06-27	MT
Wells Fargo Starts Enovis at Equalweight With $61 Price Target	22-06-16	MT
UBS Adjusts Colfax Price Target to $55 From $57, Maintains Buy Rating	22-03-16	MT
Loop Capital Adjusts Colfax's Price Target to $41 from $45, Keeps Hold Rating	22-03-15	MT
Baird Adjusts Colfax's Price Target to $44 from $47, Keeps Outperform Rating	22-03-15	MT
Morgan Stanley Adjusts Colfax's Price Target to $41 from $45, Keeps Equalweight Rating	22-03-15	MT
KeyBanc Adjusts Colfax's Price Target to $52 from $60, Keeps Overweight Rating	22-03-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

55.1 USD

Average target price

75.2 USD

Spread / Average Target

+36.48%

High Price Target

82 USD

Spread / Highest target

+48.82%

Low Price Target

65 USD

Spread / Lowest Target

+17.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Enovis Corporation

Canaccord Genuity
Needham & Co.
Stephens Inc.
UBS
William Blair & Co.
Baird
Wells Fargo Securities
Jefferies & Co.
Goldman Sachs
Evercore ISI
Argus
Loop Capital
Morgan Stanley
KeyBanc Capital Markets
Stifel Nicolaus
Seaport Global Securities
Deutsche Bank Securities
Barclays
JPMorgan Chase

Ratings for Enovis Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar